James A.
Shapiro |
Somatic hypermutation
(Cascalho, Wong et al. 1998;
Zan, Cerutti
et al. 1999; Muramatsu,
Kinoshita et al. 2000; Kinoshita and
Honjo 2001; Honjo,
Kinoshita et al. 2002; Papavasiliou
and Schatz 2002; Diaz, Ray et
al. 2003; Dickerson,
Market et al. 2003; Li, Woo et al.
2004; Shinkura, Ito
et al. 2004; Goodman and
Scharff 2005; Odegard, Kim
et al. 2005; Seki, Gearhart
et al. 2005; Casali, Pal et
al. 2006; Inlay, Gao et
al. 2006; Longerich,
Basu et al. 2006; Odegard and
Schatz 2006; Yang, Fugmann
et al. 2006; Di Noia and
Neuberger 2007; Teng and
Papavasiliou 2007; Arakawa, Kudo
et al. 2008; Chezar,
Lobel-Lavi et al. 2008; Longo,
Satorius et al. 2008; Peled, Kuang
et al. 2008; Steele 2008;
Arakawa and
Buerstedde 2009; Blagodatski,
Batrak et al. 2009; Dunnick,
Collins et al. 2009; Hackney,
Misaghi et al. 2009; Liu and Schatz
2009; Park, Zan et
al. 2009; Reynaud,
Delbos et al. 2009; Sale, Batters
et al. 2009; Steele 2009;
Maul and
Gearhart 2010; Maul and
Gearhart 2010; Tanaka, Shen
et al. 2010; Wei, Shinkura
et al. 2011)
REFERENCES
Arakawa, H. and
J. M. Buerstedde (2009). "Activation-induced cytidine
deaminase-mediated hypermutation in the DT40 cell line." Philos
Trans R Soc Lond B Biol Sci 364(1517):
639-644. http://www.ncbi.nlm.nih.gov/pubmed/19008193.
Arakawa, H., H.
Kudo, et al. (2008). "Protein evolution by hypermutation and
selection in the B cell line DT40." Nucleic Acids Res
36(1): e1. http://www.ncbi.nlm.nih.gov/pubmed/18073192.
Blagodatski, A.,
V. Batrak, et al. (2009). "A cis-acting diversification
activator both necessary and sufficient for AID-mediated
hypermutation." PLoS Genet 5(1): e1000332. http://www.ncbi.nlm.nih.gov/pubmed/19132090.
Casali, P., Z.
Pal, et al. (2006). "DNA repair in antibody somatic
hypermutation." Trends Immunol 27(7): 313-321. http://www.ncbi.nlm.nih.gov/pubmed/16737852.
Cascalho, M., J.
Wong, et al. (1998). "Mismatch repair co-opted by
hypermutation." Science 279(5354):
1207-1210. http://www.ncbi.nlm.nih.gov/pubmed/9469811.
Chezar, I., L.
Lobel-Lavi, et al. (2008). "Ongoing somatic hypermutation of
the rearranged VH but not of the V-lambda gene in
EBV-transformed rheumatoid factor-producing lymphoblastoid
cell line." Mol Immunol 46(1): 80-90. http://www.ncbi.nlm.nih.gov/pubmed/18718665.
Di Noia, J. M.
and M. S. Neuberger (2007). "Molecular mechanisms of
antibody somatic hypermutation." Annu Rev Biochem 76: 1-22. http://www.ncbi.nlm.nih.gov/pubmed/17328676.
Diaz, M., M. Ray,
et al. (2003). "Mutagenesis by AID, a molecule critical to
immunoglobulin hypermutation, is not caused by an alteration
of the precursor nucleotide pool." Mol Immunol 40(5): 261-268. http://www.ncbi.nlm.nih.gov/pubmed/12943798.
Dickerson, S. K.,
E. Market, et al. (2003). "AID mediates hypermutation by
deaminating single stranded DNA." J Exp Med\ 197\(10\):
1291-1296\. http://www.ncbi.nlm.nih.gov/pubmed/12756266\.
Dunnick, W. A.,
J. T. Collins, et al. (2009). "Switch recombination and
somatic hypermutation are controlled by the heavy chain 3'
enhancer region." J Exp Med 206(12):
2613-2623. http://www.ncbi.nlm.nih.gov/pubmed/19887393.
Goodman, M. F.
and M. D. Scharff (2005). "Identifying protein-protein
interactions in somatic hypermutation." J Exp Med\ 201\(4\):
493-496\. http://www.ncbi.nlm.nih.gov/pubmed/15710655\.
Hackney, J. A.,
S. Misaghi, et al. (2009). "DNA targets of AID evolutionary
link between antibody somatic hypermutation and class switch
recombination." Adv Immunol 101: 163-189. http://www.ncbi.nlm.nih.gov/pubmed/19231595.
Honjo, T., K.
Kinoshita, et al. (2002). "Molecular mechanism of class
switch recombination: linkage with somatic hypermutation." Annu
Rev Immunol 20:
165-196. http://www.ncbi.nlm.nih.gov/pubmed/11861601.
Inlay, M. A., H.
H. Gao, et al. (2006). "Roles of the Ig kappa light chain
intronic and 3' enhancers in Igk somatic hypermutation." J
Immunol 177(2):
1146-1151. http://www.ncbi.nlm.nih.gov/pubmed/16818772.
Kinoshita, K. and
T. Honjo (2001). "Linking class-switch recombination with
somatic hypermutation." Nat Rev Mol Cell Biol 2(7): 493-503. http://www.ncbi.nlm.nih.gov/pubmed/11433363.
Li, Z., C. J.
Woo, et al. (2004). "The generation of antibody diversity
through somatic hypermutation and class switch
recombination." Genes Dev 18(1): 1-11. http://www.ncbi.nlm.nih.gov/pubmed/14724175.
Liu, M. and D. G.
Schatz (2009). "Balancing AID and DNA repair during somatic
hypermutation." Trends Immunol\ 30(4): 173-181. http://www.ncbi.nlm.nih.gov/pubmed/19303358.
Longerich, S., U.
Basu, et al. (2006). "AID in somatic hypermutation and class
switch recombination." Curr Opin Immunol 18(2): 164-174. http://www.ncbi.nlm.nih.gov/pubmed/16464563.
Longo, N. S., C.
L. Satorius, et al. (2008). "Characterization of Ig gene
somatic hypermutation in the absence of activation-induced
cytidine deaminase." J Immunol 181(2): 1299-1306.
http://www.ncbi.nlm.nih.gov/pubmed/18606684.
Maul, R. W. and
P. J. Gearhart (2010). "AID and somatic hypermutation." Adv
Immunol 105:
159-191. http://www.ncbi.nlm.nih.gov/pubmed/20510733.
Maul, R. W. and
P. J. Gearhart (2010). "Controlling somatic hypermutation in
immunoglobulin variable and switch regions." Immunol Res
47(1-3): 113-122.
http://www.ncbi.nlm.nih.gov/pubmed/20082153.
Muramatsu, M., K.
Kinoshita, et al. (2000). "Class switch recombination and
hypermutation require activation-induced cytidine deaminase
(AID), a potential RNA editing enzyme." Cell 102(5): 553-563. http://www.ncbi.nlm.nih.gov/pubmed/11007474.
Odegard, V. H.,
S. T. Kim, et al. (2005). "Histone modifications associated
with somatic hypermutation." Immunity 23(1): 101-110. http://www.ncbi.nlm.nih.gov/pubmed/16039583.
Odegard, V. H.
and D. G. Schatz (2006). "Targeting of somatic
hypermutation." Nat Rev Immunol 6(8): 573-583. http://www.ncbi.nlm.nih.gov/pubmed/16868548.
Papavasiliou, F.
N. and D. G. Schatz (2002). "Somatic hypermutation of
immunoglobulin genes: merging mechanisms for genetic
diversity." Cell 109 Suppl: S35-44.
http://www.ncbi.nlm.nih.gov/pubmed/11983151.
Park, S. R., H.
Zan, et al. (2009). "HoxC4 binds to the promoter of the
cytidine deaminase AID gene to induce AID expression,
class-switch DNA recombination and somatic hypermutation." Nat
Immunol 10(5):
540-550. http://www.ncbi.nlm.nih.gov/pubmed/19363484.
Peled, J. U., F.
L. Kuang, et al. (2008). "The biochemistry of somatic
hypermutation." Annu Rev Immunol\ 26\: 481-511\. http://www.ncbi.nlm.nih.gov/pubmed/18304001\.
Reynaud, C. A.,
F. Delbos, et al. (2009). "Competitive repair pathways in
immunoglobulin gene hypermutation." Philos Trans R Soc
Lond B Biol Sci\ 364\(1517\):
613-619\. http://www.ncbi.nlm.nih.gov/pubmed/19010770\.
Sale, J. E., C.
Batters, et al. (2009). "Timing matters: error-prone gap
filling and translesion synthesis in immunoglobulin gene
hypermutation." Philos Trans R Soc Lond B Biol Sci 364(1517):
595-603. http://www.ncbi.nlm.nih.gov/pubmed/19008194.
Seki, M., P. J.
Gearhart, et al. (2005). "DNA polymerases and somatic
hypermutation of immunoglobulin genes." EMBO Rep 6(12): 1143-1148.
http://www.ncbi.nlm.nih.gov/pubmed/16319960.
Shinkura, R., S.
Ito, et al. (2004). "Separate domains of AID are required
for somatic hypermutation and class-switch recombination." Nat
Immunol 5(7):
707-712. http://www.ncbi.nlm.nih.gov/pubmed/15195091.
Steele, E. J.
(2008). "Reflections on the state of play in somatic
hypermutation." Mol Immunol 45(10): 2723-2726.
http://www.ncbi.nlm.nih.gov/pubmed/18359085.
Steele, E. J.
(2009). "Mechanism of somatic hypermutation: critical
analysis of strand biased mutation signatures at A:T and G:C
base pairs." Mol Immunol 46(3): 305-320. http://www.ncbi.nlm.nih.gov/pubmed/19062097.
Tanaka, A., H. M.
Shen, et al. (2010). "Attracting AID to targets of somatic
hypermutation." J Exp Med 207(2): 405-415. http://www.ncbi.nlm.nih.gov/pubmed/20100870.
Teng, G. and F.
N. Papavasiliou (2007). "Immunoglobulin somatic
hypermutation." Annu Rev Genet\ 41\: 107-120\. http://www.ncbi.nlm.nih.gov/pubmed/17576170\.
Wei, M., R.
Shinkura, et al. (2011). "Mice carrying a knock-in mutation
of Aicda resulting in a defect in somatic hypermutation have
impaired gut homeostasis and compromised mucosal defense." Nat
Immunol 12(3):
264-270. http://www.ncbi.nlm.nih.gov/pubmed/21258321.
Yang, S. Y., S.
D. Fugmann, et al. (2006). "Control of gene conversion and
somatic hypermutation by immunoglobulin promoter and
enhancer sequences." J Exp Med 203(13):
2919-2928. http://www.ncbi.nlm.nih.gov/pubmed/17178919.
Zan, H., A.
Cerutti, et al. (1999). "Induction of Ig somatic
hypermutation and class switching in a human monoclonal IgM+
IgD+ B cell line in vitro: definition of the requirements
and modalities of hypermutation." J Immunol 162(6): 3437-3447.
http://www.ncbi.nlm.nih.gov/pubmed/10092799.